The relation between oxidative stress biomarkers and atrial fibrillation after pulmonary veins isolation
Introduction
The current paradigm claims a strong link between inflammation and atrial fibrillation (AF). Several studies showed that prevalence and prognosis of AF are both associated with serum levels of inflammatory biomarkers such as C-reactive protein, tumor necrosis factor-α, interleukin-2, interleukin-6, and interleukin-8 [1], [2] The consequence of the inflammatory process is a production of free radicals, which in turn leads to increased oxidative stress which seems to be an important pathophysiological mechanism in the etiology and sustainability of AF. [3] Several studies showed a significant increase in oxidative damage in AF compared to sinus rhythm. Furthermore, gene expression associated with the production of reactive oxygen species was increased in AF. [4], [5], [6].
Radiofrequency catheter ablation is an effective treatment strategy for AF. [7], [8] However, it is thought that this procedure also induces inflammation with oxidative stress and potential arrhythmogenic substrates that may lead to an early or a late recurrence of arrhythmia. [9], [10].
The aim of our research was to study a relation between the oxidative stress (OS) biomarkers and AF burden, detected by an implantable loop recorder (ILR), before and after radiofrequency catheter ablation with pulmonary veins isolation (PVI).
Section snippets
Study population, inclusion and exclusion criteria
The study was designed as a prospective monocentric study. Total 19 consecutive patients (15 males and 4 females) with symptomatic AF undergoing PVI in the Slovak National Institute of Cardiovascular Diseases were included.
The inclusion criteria were: Age 18 or greater; planned PVI; implanted ILR at least 2 months before the PVI; symptomatic and drug refractory, paroxysmal AF characterized by spontaneous termination within 7 days of onset or persistent AF lasting more than 7 days (but not more
Baseline characteristics
Our cohort included 4 females and 15 males with a mean age of 55 ± 10 years. The most common comorbidity was arterial hypertension that occurred in almost 85% of the sample. No one had diabetes mellitus nor heart failure and there was no smoker present in the cohort. All patients were receiving equal therapy with a cardio selective long acting beta – blocker (metoprolol or bisoprolol), amiodarone and warfarin, at least 3 months prior to the ILR implantation until the first follow – up (3 months
Discussion
Our study brought a controversial insight into the mechanism of AF after the PVI. Due to the current opinion regarding the oxidative stress as a pathophysiologic factor of AF, a positive correlation of OS biomarkers and AF burden was expected. However, the results of our study showed a consistent opposite trend for all biomarkers measured. Additionally, the measurement of AGEs revealed a statistically significant negative correlation with AF burden 3 months after the PVI. The AGEs and TBARS
Limitations
In spite of the fact that the plasmatic concentrations of OS biomarkers are considered to be quite stable, there are a lot of external and internal factors that might influence their levels. It is not certain, whether the measured concentrations reflected a stable oxidative stress activity in the patients or whether it was just a reflection of actual variation influenced by current antioxidants intake, passive smoking or other free radical exposure. Another limitation of this study is the
Conclusion
In the present study, we analyzed the relation between the OS biomarkers and AF burden before and after the PVI. Our results showed a negative correlation of AGEs and TBARS concentration with AF burden after the PVI. These findings might contribute to understanding the etiology of AF after the PVI. Nevertheless, the clinical implications should be evaluated in larger and long lasting prospective studies.
Acknowledgments
This research was supported by an independent educational grant of the Slovak society of cardiology: VVS/1 – 900/90 – 12219 – 2; and from Ministry of Education, Science, Research and Sport of the Slovak Republic VEGA 2/0105/15.
References (16)
- et al.
Inflammation in atrial fibrillation
J Am Coll Cardiol
(2012) - et al.
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation
Int J Cardiol
(2007) - et al.
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society
Heart Rhythm
(2012) - et al.
Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction
Heart Rhythm
(2013 Oct) - et al.
Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation
Am J Cardiol
(2006) - et al.
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides
Cell
(1999) - et al.
Biomarkers in atrial fibrillation: an overview
Int J Clin Pract
(2014) - et al.
Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation
Circulation
(2001)
Cited by (9)
Methods to investigate advanced glycation end-product and their application in clinical practice
2022, MethodsCitation Excerpt :Furthermore, the authors documented that the significant decrease in AGEs was positively correlated with a glycated haemoglobin (HbA1c) decrease in the pioglitazone group, suggesting that the antidiabetic effects of pioglitazone may be associated with its inhibition of AGE levels [101]. Likewise, other authors described the role of oxidative stress biomarkers in AF patients [128,129]. AGEs levels have been evaluated by fluorescence spectroscopy also in healthy individuals [85–87].
The Blinding Period Following Ablation Therapy for Atrial Fibrillation: Proarrhythmic and Antiarrhythmic Pathophysiological Mechanisms
2021, JACC: Clinical ElectrophysiologyCitation Excerpt :Therefore, oxidative stress plays a possible role in AF arrhythmogenesis after ablation. Decreased plasma levels of markers of oxidative stress 3 months after PVI correlate with less AF burden after the blinding period (71). Also, immediate ablation-induced (6 h to 2 days) elevation of oxidative stress-related myeloperoxidase predicts early recurrence during week 1 post-ablation but not recurrence at 12-month follow-up (72).
Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation
2022, Journal of Interventional Cardiac ElectrophysiologyImplications of sglt inhibition on redox signalling in atrial fibrillation
2021, International Journal of Molecular SciencesMitochondrial and Sarcoplasmic Reticulum Interconnection in Cardiac Arrhythmia
2021, Frontiers in Cell and Developmental BiologyConcentration of apelin inversely correlates with atrial fibrillation burden
2021, Bratislava Medical Journal